![]() |
|
|
Forward to a colleague |
||
Access Full Stories Wyeth's manufacturing facility in Rouses Point, New York, has been spared the scrap heap, with yesterday's announcement that new pharma player Akrimax has bought up the beleaguered site... Read UK Government plans will stifle innovation, say biotechs New UK Government proposals to scrap Capital Gains Tax (CGT) relief will stifle life science innovation, according to a group of biotech small and medium enterprises (SMEs)... Read Outsourcing 'instrumental' in healthcare Outsourcing will be seen as being "instrumental" in the eyes of healthcare and biopharma firms this year as the focus on cost reduction continues to increase, according to a new report... Read Preclinical news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving Galapagos, Argenta Discovery and ChemDiv... Read Thirst for outsourcing fuelling product recalls Product recalls in the UK due to health and safety concerns have shot up to their highest level, with the rise in outsourcing to China fingerpointed for much of the blame... Read |
||||||||||||||
All News Headlines for: January | December | November |
||||||||||||||
![]() Almac improves IMP blinding services Almac Clinical Services now offer enhanced encapsulation and blinding services. Almac provides fully automated over-encapsulation for capsule batches of hundreds to millions and also a range of blinding options for inhaled products... Click Here | ||||||||||||||
|
Related Industry News EC launches major pharma industry probe The European Commission has launched an investigation into the entire European pharmaceutical sector, with surprise raids on a number of manufacturers in a bid to unearth any evidence of foul-play hampering the... Read Novo drops inhaled insulin plans in post-Exubera fallout Mere months after Pfizer's high profile exit from the inhaled insulin market in the wake of Exubera's much publicised market failure, Novo Nordisk announced late last night that it, too, has decided to halt development... Read Funding shot for cell-based vaccines A major grant has been awarded to a UK consortium working to develop predictive manufacturing tools for cell-based cancer vaccines... Read JAMA article boosts Novartis meningitis jab Novartis has been keen to shout about data published this week in the Journal of the American Medical Association (JAMA) that backs up claims that it has developed the first vaccine to protect infants against the... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||